Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             178 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Yap, M.L.
2016
12 p. e199-e205
nvt p.
artikel
2 Another Brick in the Wall … no More! Breaking the Sex Bias De Paoli, M.

12 p. 796-798
artikel
3 An Overview of the Management of Adult Ependymomas with Emphasis on Relapsed Disease Iqbal, Muhammad Shahid
2013
12 p. 726-733
8 p.
artikel
4 A Prospective Study of Diffusion-weighted Magnetic Resonance Imaging as an Early Prognostic Biomarker in Chemoradiotherapy in Squamous Cell Carcinomas of the Anus Muirhead, R.

12 p. 874-883
artikel
5 A Randomised Clinical Feasibility Trial of a Breast Immobilisation Device: The SuPPORT 4 All Bra Probst, H.

12 p. 801-810
artikel
6 Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer Leibowitz-Amit, R.
2016
12 p. 790-796
7 p.
artikel
7 A Structured Intervention to Support Early Palliative Care Conversations for Oncology Patients – A Qualitative Feasibility Study Pini, S.

12 p. e515-e522
artikel
8 A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy Parwaiz, I.

12 p. e1-e13
artikel
9 Benefits of Stereotactic Radiotherapy Fellowships to Clinical Oncology Trainees Phillips, I.
2016
12 p. e221-
1 p.
artikel
10 Bladder–Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study (Part II) Rai, B.
2015
12 p. 713-719
7 p.
artikel
11 Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers Walker, M.
2017
12 p. 818-826
9 p.
artikel
12 Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing? Drami, I.

12 p. e540-e552
artikel
13 Breast Cancer Virtual Special Issue Jena, R.
2015
12 p. 687-688
2 p.
artikel
14 Breast Radiotherapy and Heart Disease — Where Are We Now? Bartlett, F.R.
2013
12 p. 687-689
3 p.
artikel
15 Building a New Model of Care for Rapid Breast Radiotherapy Treatment Planning: Evaluation of the Advanced Practice Radiation Therapist in Cavity Delineation Lee, G.
2016
12 p. e184-e191
nvt p.
artikel
16 Can Optical Surface Imaging Replace Non-coplanar Cone-beam Computed Tomography for Non-coplanar Set-up Verification in Single-isocentre Non-coplanar Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Single and Multiple Brain Metastases? Lai, J.L.

12 p. e657-e665
artikel
17 Can Protons or Altered Fractionation Decrease Neurotoxicity after Chemoradiation in Head and Neck Cancer? Benghiat, H.
2014
12 p. 762-764
3 p.
artikel
18 Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma Martin, A.
2018
12 p. 756-763
artikel
19 Chemoradiotherapy in Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma. Cetuximab is Inferior to Cisplatin – is the Case now Closed? Donnelly, O.

12 p. 783-785
artikel
20 Clinical Impact of Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Carried Out for Non-Medicare Eligible Indications in Australia: A Prospective Study Lin, P.
2015
12 p. 753-754
2 p.
artikel
21 Clinical Outcome of Exclusively Radiographer-led Delivery of Postoperative Vaginal Vault Brachytherapy for Endometrial Cancer – The Addenbrooke's Experience Buckley, H.

12 p. 844-849
artikel
22 Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy Walser, M.

12 p. e578-e585
artikel
23 Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis Subiela, J.D.

12 p. e676-e688
artikel
24 Comparative Dosimetric Analysis and Normal Tissue Complication Probability Modelling of Four-Dimensional Computed Tomography Planning Scans Within the UK NeoSCOPE Trial Nicholas, O.

12 p. 828-834
artikel
25 Concurrent Cetuximab-based bioradiotherapy versus Cisplatin-based Chemoradiotherapy in the Definitive Management of Favourable Biology Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma: Systematic Review and Meta-analysis Swain, M.

12 p. 786-795
artikel
26 Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival Rupasinghe, T.

12 p. 765-772
artikel
27 Current Status of Anatomical Magnetic Resonance Imaging in Brachytherapy and External Beam Radiotherapy Planning and Delivery Ingle, M.

12 p. 817-827
artikel
28 Data Mining in Oncology: The ukCAT Project and the Practicalities of Working with Routine Patient Data Price, G.
2017
12 p. 814-817
4 p.
artikel
29 Deep-learning Method for the Prediction of Three-Dimensional Dose Distribution for Left Breast Cancer Conformal Radiation Therapy Ravari, M.E.

12 p. e666-e675
artikel
30 Definitive Stereotactic Body Radiation Therapy in Early-Stage Solitary Hepatocellular Carcinoma: An Australian Multi-Institutional Review of Outcomes Liu, H.Y.-h.

12 p. 787-793
artikel
31 Developing UK Guidance on How Long Men Should Abstain from Receiving Anal Sex before, During and after Interventions for Prostate Cancer Ralph, S.

12 p. 807-810
artikel
32 Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment Appleyard, S.E.

12 p. 751-760
artikel
33 Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer? Yahya, S.
2016
12 p. e216-e219
nvt p.
artikel
34 Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial Mittal, A.

12 p. e553-e560
artikel
35 Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? Arcangeli, S.
2013
12 p. 739-740
2 p.
artikel
36 Dosimetric Advantages and Superior Treatment Delivery Efficiency of RapidArc over Conventional Intensity-modulated Radiotherapy in High-risk Prostate Cancer Involving Seminal Vesicles and Pelvic Nodes Poon, D.M.C.
2013
12 p. 706-712
7 p.
artikel
37 Early Phase Clinical Trial Designs – State of Play and Adapting for the Future Harrington, J.A.
2017
12 p. 770-777
8 p.
artikel
38 Efficacy and Tolerance of Carboplatin plus Cetuximab (Simplified EXTREME Regimen) in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Le Roy, C.

12 p. e473-e481
artikel
39 Elective Management of the Neck in Parotid Tumours Ng-Cheng-Hin, B.
2018
12 p. 764-772
artikel
40 Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation Sood, S.
2015
12 p. 720-727
8 p.
artikel
41 Evaluation of Ultra-low-dose Paediatric Cone-beam Computed Tomography for Image-guided Radiotherapy Bryce-Atkinson, A.

12 p. 835-844
artikel
42 Evolving Practice Pattern of Palliative Radiation Therapy for Bone Metastases from Lung Cancer in Australia Ong, W.L.

12 p. e530-e539
artikel
43 External Beam Radiotherapy in Western Africa: 1969–2019 Taku, N.

12 p. e511-e520
artikel
44 Five Year Prostate-specific Antigen Outcomes after Caesium Prostate Brachytherapy Benoit, R.M.
2014
12 p. 776-780
5 p.
artikel
45 Fractionated Stereotactic Radiotherapy for Acoustic Neuromas: Long-term Outcomes Woolf, D.K.
2013
12 p. 734-738
5 p.
artikel
46 Functional Imaging in Radiotherapy in the Netherlands: Availability and Impact on Clinical Practice Vogel, W.V.
2016
12 p. e206-e215
nvt p.
artikel
47 Functional Imaging to Predict Treatment Response in Head and Neck Cancer: How Close are We to Biologically Adaptive Radiotherapy? Paterson, C.

12 p. 861-873
artikel
48 Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Madala, S.

12 p. 799-809
artikel
49 Geographical Variation in Underlying Social Deprivation, Cardiovascular and Other Comorbidities in Patients with Potentially Curable Cancers in England: Results from a National Registry Dataset Analysis Waterhouse, J.V.

12 p. e708-e719
artikel
50 Granulocyte Colony-stimulating Factor-producing Upper Urinary Tract Carcinoma: Systematic Review of 46 Cases Reported in Japan Matsumoto, K.
2014
12 p. 781-788
8 p.
artikel
51 Guidelines for Clinical Target Volume Definition for Perineural Spread of Major Salivary Gland Cancers Armstrong, K.
2018
12 p. 773-779
artikel
52 High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients D'Agostino, G.
2016
12 p. e173-e178
nvt p.
artikel
53 Iatrogenic Menopause After Treatment for Cervical Cancer Moss, E.L.
2016
12 p. 766-775
10 p.
artikel
54 IBC filler advert REVIEWERS_COL 2013
12 p. IBC-
1 p.
artikel
55 Image-Guided Radiotherapy for Pelvic Cancers: A Review of Current Evidence and Clinical Utilisation Webster, A.

12 p. 805-816
artikel
56 Image-Guided Radiotherapy – The Unsung Hero of Radiotherapy Development Muirhead, R.

12 p. 789-791
artikel
57 Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver Dhont, J.

12 p. 792-804
artikel
58 Implementing Head and Neck Contouring Peer Review without Pathway Delay: The On-demand Approach Fong, C.
2017
12 p. 841-847
7 p.
artikel
59 Implementing Intensity-modulated Radiotherapy with Simultaneous Integrated Boost for Anal Cancer: 3 Year Outcomes at Two Sydney Institutions Yates, A.
2015
12 p. 700-707
8 p.
artikel
60 Improved Education Should be provided to Healthcare Workers and to the Community to Increase Human Papillomavirus Vaccination Coverage in Adolescent Males Marks, K.

12 p. e616
artikel
61 Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UK Khoja, L.
2016
12 p. 760-765
6 p.
artikel
62 Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study Vreugdenhil, M.

12 p. 795-803
artikel
63 Improving Clinical Oncology Trainees' Radiotherapy Induction Thippu Jayaprakash, K.
2016
12 p. e220-
1 p.
artikel
64 Improving Outcomes with Chemoradiotherapy in the Mucosal Squamous Cell Carcinomas – Immune Checkpoint Inhibition and Broken Promises Samuel, R.

12 p. 764-768
artikel
65 Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform Gilson, C.
2017
12 p. 778-786
9 p.
artikel
66 Infections in Patients with Advanced-stage Epidermal Growth Factor Receptor-mutant Lung Cancer – a Post-hoc Analysis of a Randomised Trial Sahu, H.

12 p. 811-812
artikel
67 Influence of a Regional Centralised Upper Gastrointestinal Cancer Service Model on Patient Safety, Quality of Care and Survival Chan, D.S.Y.
2013
12 p. 719-725
7 p.
artikel
68 Innovative Solutions for Clinical Trial Follow-up: Adding Value from Nationally Held UK Data Appleyard, S.E.
2017
12 p. 789-795
7 p.
artikel
69 In Response to Lewis et al. Chang, J.

12 p. e613
artikel
70 Instant Oncology: The BC2001/BCON Meta-Analysis Wang, L.

12 p. 745-746
artikel
71 Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial De Felice, F.

12 p. 788-794
artikel
72 Is Africa a ‘Graveyard’ for Linear Accelerators? Reichenvater, H.
2016
12 p. e179-e183
nvt p.
artikel
73 Is this the Start of a New Era in Medicine? Media Influences Practice and Research Verma, M.

12 p. 819-820
artikel
74 Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review Saha, A.

12 p. e493-e504
artikel
75 Locoregional Treatment in Early Stage Breast Cancer: More Evidence and Yet More Questions? Poortmans, P.M.
2015
12 p. 689-691
3 p.
artikel
76 Long-term Overall Survival after External Beam Radiotherapy for Localised Prostate Cancer Jahreiβ, M.-C.

12 p. e689-e698
artikel
77 Lower Respiratory Tract Adenoid Cystic Carcinoma: Its Management in the Past Decades Hsu, A.A.L.
2015
12 p. 732-740
9 p.
artikel
78 Malignant Mesothelioma, Hypoalbuminaemia and the Effect of Carboplatin/Pemetrexed on Survival Murphy, S.
2013
12 p. 713-718
6 p.
artikel
79 Management Perspective on How to Plan and Deliver Image-guided Radiotherapy – Experience of the Oxford Cancer Centre Over the Past 10 Years Drummond, L.

12 p. 845-851
artikel
80 Measuring the Quality of Personal Care in Patients Undergoing Radiotherapy for Prostate Cancer Foley, K.A.
2017
12 p. 827-834
8 p.
artikel
81 Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes Lin, P.

12 p. e586-e598
artikel
82 Modern Challenges of Cancer Clinical Trials Ajithkumar, T.V.
2017
12 p. 767-769
3 p.
artikel
83 Multi-arm Clinical Trials – Teams within Teams Langley, R.E.
2017
12 p. 787-788
2 p.
artikel
84 Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone? Munro, A.J.
2015
12 p. 728-731
4 p.
artikel
85 Multidisciplinary Team Meetings in Cancer Care: We Could and Should do Better Than This Valdagni, R.
2016
12 p. 799-800
2 p.
artikel
86 Multidisciplinary Team Service Redesign: a Step to Improved Quality of Care for Lung Cancer Patients Salem, A.
2016
12 p. 800-801
2 p.
artikel
87 Multidisciplinary Team Tumour Boards are a Lifeline for Our Cancer Patients in Lower and Middle Income Countries Abbasi, A.N.
2016
12 p. 799-
1 p.
artikel
88 Multileaf Collimation Cardiac Shielding in Breast Radiotherapy: Cardiac Doses are Reduced, But at What Cost? Bartlett, F.R.
2013
12 p. 690-696
7 p.
artikel
89 Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review Haider, M.A.

12 p. e599-e612
artikel
90 Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference? Kane, S.
2015
12 p. 751-753
3 p.
artikel
91 Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer Welsh, L.C.
2014
12 p. 765-775
11 p.
artikel
92 Ninety Day Mortality After Radical Radiotherapy for Head and Neck Cancer Dixon, L.
2017
12 p. 835-840
6 p.
artikel
93 Nomogram Based on Clinical and Radiomics Data for Predicting Radiation-induced Temporal Lobe Injury in Patients with Non-metastatic Stage T4 Nasopharyngeal Carcinoma Bin, X.

12 p. e482-e492
artikel
94 Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival Franzese, C.

12 p. e649-e656
artikel
95 OncoFlash–Research Updates in a Flash! (December 2022) Simões, R.

12 p. 781-782
artikel
96 OncoFlash – Research Updates in a Flash! (December 2023 edition) Crockett, C.

12 p. 761-763
artikel
97 Patients' Acceptability of Different Fentanyl Products for Breakthrough Cancer Pain Mercadante, S.
2014
12 p. 806-
1 p.
artikel
98 Peer Review of Radiotherapy Planning: Quantifying Outcomes and a Proposal for Prospective Data Collection Mackenzie, J.
2016
12 p. e192-e198
nvt p.
artikel
99 POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases Goyal, A.
2015
12 p. 692-695
4 p.
artikel
100 Postgraduate Global Health Competency Profile for Radiation Oncology Oar, A.
2018
12 p. 810-816
artikel
101 Postoperative Radiotherapy in Human Papilloma Virus-positive Oropharyngeal Tumours — A Survey of Target Volume Delineation, Dose Prescription and Treatment Verification among UK Oncologists Owadally, W.S.
2014
12 p. 804-805
2 p.
artikel
102 Practice Change after Evaluation of an Offline Correction Protocol for Image-guided Radiotherapy in Head and Neck Cancer Forker, L.
2015
12 p. 750-751
2 p.
artikel
103 Predicting 2-Year Survival for Radiation Regimens in Advanced Non-small Cell Lung Cancer Sharieff, W.
2013
12 p. 697-705
9 p.
artikel
104 Prospective Phase II Study of the Efficacy of Transcutaneous Electrical Nerve Stimulation in Post-radiation Patients Vijayan, A.
2014
12 p. 743-747
5 p.
artikel
105 Prostate Bed Radiation Therapy: The Utility of Ultrasound Volumetric Imaging of the Bladder Haworth, A.
2014
12 p. 789-796
8 p.
artikel
106 Prostate Hypofractionated Radiotherapy Trial Results Need to be Interpreted with Caution due to Undertreatment of the Control Arm in the CHHiP Trial Sivanandan, M.A.
2016
12 p. 797-
1 p.
artikel
107 Prostate Stereotactic Body Radiotherapy — First UK Experience Tree, A.C.
2014
12 p. 757-761
5 p.
artikel
108 Proton Beam Therapy: The Context, Future Direction and Challenges Become Clearer Crellin, A.M.
2014
12 p. 736-738
3 p.
artikel
109 Quality of Radiation Therapy Referral and Utilisation Post-prostatectomy: A Population-based Study of Time Trends Jin, C.J.
2016
12 p. 783-789
7 p.
artikel
110 Radiation-induced Lumbosacral Plexopathy after Spine Stereotactic Body Radiotherapy – Should the Lumbosacral Plexi be Contoured? Tjong, M.C.

12 p. 884-886
artikel
111 RADICAL(S) Radiotherapy Post-prostatectomy, Current and Future Practice McGrane, J.
2018
12 p. 793-797
artikel
112 RCR Meetings
12 p. I
artikel
113 RCR Meetings 2014
12 p. I-
1 p.
artikel
114 RCR Meetings 2017
12 p. I-
1 p.
artikel
115 RCR Meetings 2015
12 p. I-
1 p.
artikel
116 RCR Meetings 2016
12 p. I-
1 p.
artikel
117 RCR Meetings 2013
12 p. I-
1 p.
artikel
118 RCR Meetings 2018
12 p. I
artikel
119 RCR Meetings
12 p. I
artikel
120 RCR Meetings
12 p. I
artikel
121 RCR Meetings
12 p. I
artikel
122 Recommendations for Randomised Trials in Surgical Oncology Glasbey, J.C.
2017
12 p. 799-810
12 p.
artikel
123 Reducing Gender Disparity in Oncologists in India: An Opportunity to Address Workforce Challenges Chopra, S.
2018
12 p. 805-809
artikel
124 Reducing the Risk of Death From Pneumocystis jirovecii Pneumonia After Radical Radiation Therapy to the Lung McAleese, J.

12 p. 780-787
artikel
125 Reflections on the Physics of Compton Scatter Greenberg, A.

12 p. e617
artikel
126 Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy Cozma, A.I.

12 p. 773-779
artikel
127 Relative Biological Effect/Linear Energy Transfer in Proton Beam Therapy: A Primer Gulliford, S.L.

12 p. 809-812
artikel
128 Respiratory-gated 18F Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging in Evaluation of Primary Gastric Lesions and Gastric Lymph Nodes in Patients with Gastric Cancer Gülbahar Ateş, S.

12 p. 810-818
artikel
129 Response to: Sivanandan et al. Prostate Hypofractionated Radiotherapy Trial Results Need to be Interpreted with Caution due to Undertreatment of the Control Arm in the CHHiP Trial Dearnaley, D.
2016
12 p. 798-799
2 p.
artikel
130 Response to: The Survival Time of 8376 Male Breast Cancer Patients Wan, B.A.
2018
12 p. 818-819
artikel
131 Risk of Death from Pneumocystis jirovecii after Curative-intent Radiotherapy for Lung Cancer McAleese, J.
2018
12 p. e81-e82
artikel
132 Science in Focus: Circulating Tumour DNA as a Liquid Biopsy O'Leary, B.
2016
12 p. 735-738
4 p.
artikel
133 Science in Focus: Genomic Instability and its Implications for Clinical Cancer Care Ahmad, S.S.
2018
12 p. 751-755
artikel
134 Selective Internal Radiotherapy of the Liver: At the Crossroads of Interventional Oncology Research and National Health Service Commissioning Sharma, R.A.
2014
12 p. 733-735
3 p.
artikel
135 Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy? Ostler, P.

12 p. 747-748
artikel
136 Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No Macbeth, F.

12 p. 749-750
artikel
137 Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers Greenwood, H.

12 p. 773-786
artikel
138 Solitary Fibrous Tumour: A Single Institution Retrospective Study and Further Validation of a Prognostic Risk Assessment System Friis, R.B.
2018
12 p. 798-804
artikel
139 Stereotactic Body Radiotherapy for Spine Oligometastases: A Multicentre Retrospective Study From the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Cuccia, F.

12 p. 794-800
artikel
140 Stereotactic Body Radiotherapy in Metastatic Disease: The Known Unknowns and the Unknown Unknowns Tree, A.C.

12 p. 813-814
artikel
141 Stereotactic Body Radiotherapy Virtual Special Issue Jena, R.
2016
12 p. 733-734
2 p.
artikel
142 Stereotactic Radiosurgery (SRS) with Volumetric Modulated Arc Therapy (VMAT): Interim Results of a Multi-arm Phase I Trial (DESTROY-2) Deodato, F.
2014
12 p. 748-756
9 p.
artikel
143 Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment Ige, T.A.

12 p. e521-e529
artikel
144 Survey on Adaptive Radiotherapy Practice Krishnatry, R.
2018
12 p. 819
artikel
145 Survival Differences of Patients with Resected Extraskeletal Osteosarcoma Receiving Two Different (Neo)Adjuvant Chemotherapy Regimens: A Systematic Review and Meta-analysis Campos, F.

12 p. e720-e727
artikel
146 Survival Outcomes Following Discontinuation of Ipilimumab and Nivolumab for Advanced Melanoma in a Population-based Cohort Ksienski, D.

12 p. e561-e569
artikel
147 Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status Robinson, S.D.

12 p. e614
artikel
148 Taxane-based Induction Chemotherapy Plus Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma: Prospective Results from a Non-endemic Cohort Ghosh-Laskar, S.

12 p. 850-857
artikel
149 Temporal Profiles of Symptom Scores After Palliative Radiotherapy for Bleeding Gastric Cancer With Adjustment for the Palliative Prognostic Index: An Exploratory Analysis of a Multicentre Prospective Observational Study (JROSG 17–3) Kawamoto, T.

12 p. e505-e514
artikel
150 The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up Bhattacharya, I.S.
2017
12 p. 796-798
3 p.
artikel
151 The Assessment of Deaths after Radiotherapy is an Essential Part of Service Evaluation — Results of a 30 Day Mortality Audit of Patient Deaths after Palliative Radiotherapy Boardman, A.
2014
12 p. 807-
1 p.
artikel
152 The Challenge Facing Academic Radiotherapy Physics in the UK Hounsell, A.R.

12 p. 858-860
artikel
153 The CONVERT Trial: Interpretation, Journey and Lessons Learnt Faivre-Finn, C.
2017
12 p. 811-813
3 p.
artikel
154 The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively? Patel, P.H.

12 p. 824-833
artikel
155 The Effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on Population-based Treatment and Survival for Squamous Cell Cancer of the Anus Downing, A.
2015
12 p. 708-712
5 p.
artikel
156 The Effect of Waiting Times for Postoperative Radiotherapy on Outcomes for Women Receiving Partial Mastectomy for Breast Cancer: a Systematic Review and Meta-Analysis Gupta, S.
2016
12 p. 739-749
11 p.
artikel
157 The Effects of Human Papillomavirus Status and Treatment on the Positive Predictive Value of Post-radiotherapy 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in Advanced Head and Neck Squamous Cell Carcinoma Zhou, S.

12 p. e699-e707
artikel
158 The Impact of Combined Radiation and Chemotherapy on Outcome in Uterine Clear Cell Carcinoma Compared with Chemotherapy Alone Mahdi, H.
2016
12 p. 776-782
7 p.
artikel
159 The Impact of ‘Lockdown’ on Medical Oncology Services in Sri Lanka Karunaratne, B.

12 p. e615
artikel
160 The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the Clinic Chan Wah Hak, C.

12 p. 769-772
artikel
161 The Pivotal Role of the Therapeutic Radiographer/Radiation Therapist in Image-guided Radiotherapy Research and Development Duffton, A.

12 p. 852-860
artikel
162 The REQUITE Project: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-effects and Improve Quality of Life in Cancer Survivors West, C.
2014
12 p. 739-742
4 p.
artikel
163 The Road Map for Proton Therapy Sikora, K.
2018
12 p. 817
artikel
164 The Road Map for Proton Therapy: Reply to Professor Karol Sikora Crellin, A.
2018
12 p. 817-818
artikel
165 The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer Otter, S.J.

12 p. 834-843
artikel
166 The Role of Elective Para-aortic Lymph Node Irradiation in Patients with Locally Advanced Cervical Cancer Yap, M.L.
2014
12 p. 797-803
7 p.
artikel
167 The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust Crockett, C.

12 p. 761-764
artikel
168 The Value of Patient and Public Involvement in Trial Design and Development Gasson, S.
2015
12 p. 747-749
3 p.
artikel
169 Trainee Oncologists Experience of Flexible Nasal Endoscopy in the Head and Neck Clinic Hughes, J.
2015
12 p. 751-
1 p.
artikel
170 Treatment Compliance in Lung Cancer Patients Julka, P.K.
2015
12 p. 754-755
2 p.
artikel
171 Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy Illidge, T.
2015
12 p. 696-699
4 p.
artikel
172 Understanding Patients Referred to a Tertiary Cancer Centre for a Second Opinion Acaster, S.

12 p. e618
artikel
173 Understanding Statistical Significance and Avoiding Common Pitfalls Robinson, R.

12 p. 804-806
artikel
174 Use of Diffusion-Weighted Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma Noij, D.P.
2018
12 p. 780-792
artikel
175 Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland Dobson, R.
2015
12 p. 741-746
6 p.
artikel
176 Waiting Time Intervals for Non-small Cell Lung Cancer Diagnosis and Treatment in Alberta: Quantification of Intervals and Identification of Risk Factors Associated with Delays Kim, J.O.A.
2016
12 p. 750-759
10 p.
artikel
177 What Can Proton Beam Therapy Achieve for Patients with Pectus Excavatum Requiring Left Breast, Axilla and Internal Mammary Nodal Radiotherapy? Settatree, S.

12 p. e570-e577
artikel
178 When Should we Irradiate the Primary in Metastatic Lung Cancer? Shiarli, A.-M.

12 p. 815-823
artikel
                             178 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland